| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |